Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-14T23:04:38.384Z Has data issue: false hasContentIssue false

Pain and Addiction in Specialty and Primary Care: The Bookends of a Crisis

Published online by Cambridge University Press:  01 January 2021

Extract

Specialists and primary care physicians play an integral role in treating the twin epidemics of pain and addiction. But inadequate access to specialists causes much of the treatment burden to fall on primary physicians. This article chronicles the differences between treatment contexts for both pain and addiction — in the specialty and primary care contexts — and derives a series of reforms that would empower primary care physicians and better leverage specialists.

Type
Symposium Articles
Copyright
Copyright © American Society of Law, Medicine and Ethics 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baker, D.W., “History of the Joint Commission’s Pain Standards: Lessons for Today’s Prescription Opioid Epidemic,” JAMA 317, no. 11 (2017): 1117-1118, at 1117.Google Scholar
Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Prescribing Data, August 30, 2017, available at <https://www.cdc.gov/drugoverdose/data/prescribing.html> (last visited February 14, 2018).+(last+visited+February+14,+2018).>Google Scholar
Jones, C.M., Campopiano, M., Baldwin, G., and McCance-Katz, E., “National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment,” American Journal of Public Health 105, No. 8 (2015): e55-e63.Google Scholar
American Board of Preventative Medicine, Press Release, Addiction Medicine Subspecialty Certification Examination to be Administered in 2017, available at <https://www.abam.net/wp-content/uploads/2015/01/ABPM-TAMF-Press-Release-Nov.-30-2016.pdf> (last visited February 14, 2018).+(last+visited+February+14,+2018).>Google Scholar
Turner, L., Kruszewski, S.P., and Alexander, G.C., “Trends in the Use of Buprenorphine by Office-Based Physcians in the United States, 2003-2013,” American Journal on Addictions 24, no. 1 (2015): 24-29, at 24, 26.Google Scholar
Brener, L., von Hippel, W., von Hippel, C., Resnick, I., and Treloar, C., “Perceptions of Discriminatory Treatment by Staff as Predictors of Drug Treatment Completion: Utility of a Mixed Methods Approach,” Drug and Alcohol Review 29 (2010): 491497.CrossRefGoogle Scholar
Bonnie, R.J., Kesselheim, A.S., and Clark, D.J., “Both Urgency and Balance Needed in Addressing the Opioid Epidemic: A Report From the National Academies of Sciences, Engineering, and Medicine,” JAMA 318, no. 5 (2017): 423-424.Google Scholar
American Society of Addiction Medicine, Opioid Addiction 2016 Facts & Figures, available at <https://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf> (last visited April 2, 2018).+(last+visited+April+2,+2018).>Google Scholar
Center for Disease Control and Prevention, Morbidity and Mortality Weekly Report, “Vital Signs: Overdoses of Prescription Opioid Pain Relievers --- United States, 1999—2008,” available at <https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm?s_cid=mm6043a4_w#fig2; https://turnthetiderx.org/> (last visited May 31, 2018).+(last+visited+May+31,+2018).>Google Scholar
National Institutes of Health, Fact Sheet, “Pain Management,” October 2010, available at <https://report.nih.gov/nihfact-sheets/ViewFactSheet.aspx?csid=57> (last visited February 14, 2018).+(last+visited+February+14,+2018).>Google Scholar
Gaskin, D.J. and Richard, P., “The Economic Costs of Pain in the United States,” The Journal of Pain 13, no. 8 (2012): 715-724.CrossRefGoogle Scholar
See American Society of Addiction Medicine, supra note 8.Google Scholar
De Vries, T.J. and Shippenberg, T.S., “Neural Systems Underlying Opiate Addiction,” Journal of Neuroscience 22, no. 9 (2002): 3321-3325.Google Scholar
Brat, G.A. et al., “Postsurgical Prescriptions for Opioid naïve Patients and Association with Overdose and Misuse: Retrospective Cohort Study,” BMJ 360 (2018).Google Scholar
Cicero, T.J., Ellis, M.S., Surratt, H.L., and Kurtz, S.P., “The changing face of heroin use in the United States: a retrospective analysis of the past 50 years,” JAMA Psychiatry 71, no. 7 (2014): 821-826.Google Scholar
Breuer, B., Cruciani, R., and Portenoy, R.K., “Pain Management by Primary Care Physicians, Pain Physicians, Chiropractors, and Acupuncturists: a National Survey,” Southern Medical Journal 103, no. 8 (2010): 738-747, at 742.Google Scholar
Matthias, M.S. et al., “The Patient-Provider Relationship in Chronic Pain Care; Providers’ Perspectives,” Pain Medicine 11, no. 11 (2010): 1688-1697.Google Scholar
Upshur, C.C., Luckmann, R.S., and Savageau, J.A., “Primary Care Provider Concerns about Management of Chronic Pain in Community Clinic Populations,” Journal of General Internal Medicine 21, no. 6 (2006): 652-655, at 652.Google Scholar
Lipari, R.N., Park-Lee, E., and Van Horn, S., “America’s Need for and Receipt of Substance Use Treatment in 2015, >Substance and Mental Health Services Administration (September 29, 2016), available at <https://www.samhsa.gov/data/sites/default/files/report_2716/ShortReport-2716.html> (last visited February 14, 2018).Substance+and+Mental+Health+Services+Administration+(September+29,+2016),+available+at++(last+visited+February+14,+2018).>Google Scholar
Judge, David L. Bazelon Center for Mental Health Law, “Primary Care Providers’ Role in Mental Health,” available at <http://naapimha.org/wordpress/media/Primary-Care-Providers%E2%80%99-Role-in-Mental-Health.pdf> (last visited February 14, 2018).+(last+visited+February+14,+2018).>Google Scholar
Yarnall, K.S. et al., “Primary Care: Is There Enough Time for Prevention?” American Journal of Public Health 93, no. 4 (2003): 635-641, at 635.CrossRefGoogle Scholar
Fishman, S., Ballantyne, J., and Rathmell, J.P., Bonica’s Management of Pain: Fourth Edition (Baltimore: Lippincott, Williams & Wilkins, 2010): at XIX.Google Scholar
Tompkins, D.A., Hobelmann, J.G., and Compton, P., “Providing Chronic Pain Management in the ‘Fifth Vital Sign’ Era: Historical and Treatment Perspectives on a Modern-Day Medical Dilemma,” Drug and Alcohol Dependence 173, no. 1 (2017): S11-21.Google Scholar
Gudas, L., “Raymond W. Houde M.D.,” New York Times, Obituaries (March 16, 2006), available at <http://www.legacy.com/obituaries/nytimes/obituary.aspx?n=raymond-w-houdemd&pid=17098184> (last visited April 3, 2018).+(last+visited+April+3,+2018).>Google Scholar
Seymour, J., “Pain and Palliative Care: The Emergence of New Specialties,” Journal of Pain and Symptom Management 29, no. 1 (2005): 2-13.Google Scholar
Buffer, J.C., “A Message from the President,” The Phoenix: A Diplomates Newsletter (Winter 2014), available at <https://www.theabfm.org/news.aspx?year=2014#d635541984> (last visited February 21, 2018).+(last+visited+February+21,+2018).>Google Scholar
Max, M.B., Perspective, “Improving Outcomes of Analgesic Treatment: Is Education Enough?,” Annals of Internal Medicine 113, no. 11 (1990): 885-889. 28. Id. at 886.Google Scholar
See Department of Veterans Affairs, Pain as the 5th Vital Sign Toolkit, October 2000, available at <https://www.va.gov/PAINMANAGEMENT/docs/Pain_As_the_5th_Vital_Sign_Toolkit.pdf> (last visited February 21, 2018): at 5.+(last+visited+February+21,+2018):+at+5.>Google Scholar
See Department of Veterans Affairs, supra note 29.Google Scholar
See Brennan, F., “The U.S. Congressional ‘Decade on Pain Control and Research’ 2001-2011: A Review,” Journal of Pain & Palliative Care Pharmacotherapy 29, no. 3 (2015).Google Scholar
Nelson, R., “Decade of Pain Control and Research gets into Gear in USA,” Lancet 362 (October 4, 2003), available at <https://ac.els-cdn.com/S0140673603145059/1-s2.0-S0140673603145059-main.pdf?_tid=18e03d6e-014d-11e8-bb6d-00000aacb35e&acdnat=1516829308_46681b426a4fe3832276deef3e8b8662> (last visited February 21, 2018).CrossRefGoogle Scholar
Joint Commission on Accreditation of Healthcare Organizations, Pain Standards for 2001, available at <https://www.jointcommission.org/assets/1/6/2001_Pain_Standards.pdf> (last visited February 21, 2018): at 2.+(last+visited+February+21,+2018):+at+2.>Google Scholar
Phillips, D.M., Medical News & Perspectives, “JCHO Pain Management Standards Are Unveiled,” JAMA 284, no. 4 (2000): 428-429.Google Scholar
See Joint Commission on Accreditation of Healthcare Organizations, supra note 33 at 3.Google Scholar
Zgierska, A., Rabago, D., and Miller, M.M., “Impact of Patient Satisfaction Ratings on Physicians and Clinical Care,” Patient Preference and Adherence 8 (2014): 437-446.CrossRefGoogle Scholar
See Asbury, K., “Four Cities File Lawsuit against Joint Commission on Accreditation of Health Care Organizations,” West Virginia Record, November 2, 2017, available at <https://wvrecord.com/stories/511258712-four-cities-file-lawsuit-against-joint-commission-on-accreditation-of-health-care-organizations> (last visited February 21, 2018).+(last+visited+February+21,+2018).>Google Scholar
“Joint Commission Enhances Pain Assessment and Management Requirements for Accredited Hospitals,” The Joint Commission Perspectives 37, no.7 (2017): 2-4.Google Scholar
Zee, A.V., Tthe Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy,” American Journal of Public Health 99, no. 2 (2009).Google Scholar
See Keefe, P.R., “The Family That Built An Empire of Pain,” The New Yorker, October 30, 2017, available at <https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain> (last visited February 21, 2018).+(last+visited+February+21,+2018).>Google Scholar
Addy, J., “Opioid Companies Sued by York County No Strangers to Lawsuits, Settlements,” York Dispatch, December 11, 2017, available at <https://www.yorkdispatch.com/story/news/2017/12/11/opioid-companies-sued-york-county-no-strangers-lawsuits-settlements/942431001/> (last visited February 21, 2018).+(last+visited+February+21,+2018).>Google Scholar
See Kertesz, S.G., Gordon, A.J., and Satel, S.L., “Opioid Prescription Control: When the Corrective Goes Too Far,” HealthAffairs, January 19, 2018, available at <https://www.healthaffairs.org/do/10.1377/hblog20180117.832392/full/> (last visited February 22, 2018).+(last+visited+February+22,+2018).>Google Scholar
Atkinson, T.J., Schatman, M.E., and Fudin, J., “The damage done by the war on opioids: the pendulum has swung too far,” editorial, Journal of Pain Research 7 (2014): 265-268.Google Scholar
See Kertesz, supra note 43.Google Scholar
Olsen, Y., Daumit, G.L., and Ford, D.E., “Opioid Prescriptions by U.S. Primary Care Physicians from 1992 to 2001,” The Journal of Pain 7, no. 4 (2006): 225-235, at 228.CrossRefGoogle Scholar
See Levy, B., Paulozzi, L., Mack, K.A., and Jones, C.M., “Trends in Opioid Analgesic–Prescribing Rates by Specialty, U.S., 2007–2012,” American Journal of Preventive Medicine 49, no. 3 (2015): 409-413, at 409.Google Scholar
Gatchel, R.J., “Comorbidity of Chronic Pain and Mental Health Disorders: The Biopsychosocial Perspective,” American Psychologist 59, no. 8 (2004): 795-805.CrossRefGoogle Scholar
See Krebs, E.E., Carey, T.S., and Weinberger, M., “Accuracy of the Pain Numeric Rating Scale as a Screening Test in Primary Care,” Journal of General Internal Medicine 22, no. 10 (2007): 14531458.CrossRefGoogle Scholar
Mezei, L. and Murinson, B.B., “Pain Education in North American Medical Schools,” Journal of Pain 12, no. 12 (2011): 1199-1208.CrossRefGoogle Scholar
Chiu, A.S. et al., “Trainees as Agents of Change in the Opioid Epidemic: Optimizing the Opioid Prescription Practices of Surgical Residents,” Journal of Surgical Education 75, no. 1 (2018): 65-71.CrossRefGoogle Scholar
Yanni, L.M. et al., “Preparation, Confidence, and Attitudes About Chronic Noncancer Pain in Graduate Medical Education,” Journal of Graduate Medical Education 2, no. 2 (2010): 260-268.CrossRefGoogle Scholar
Starrels, J.L. et al., “Low use of Opioid Risk Reduction Strategies in Primary Care Even for High Risk Patients with Chronic Pain,” Journal of General Internal Medicine 26, no. 9 (2011): 958964, at 958, 961.CrossRefGoogle Scholar
Dowell, D., Haegerich, T.M, and Chou, R., “CDC Guideline for Prescribing Opioids for Chronic Pain – United States, 2016,” JAMA 315, no. 15 (2016): 1624-1645.CrossRefGoogle Scholar
Bronstein, K. et al., “Can Clinicians Accurately Predict which Patients are Misusing Their Medications?,” The Journal of Pain 12, no. 4 (2011):P3.CrossRefGoogle Scholar
See Geraghty, E.M., Franks, P., and Kravitz, R.L., “Primary Care Visit Length, Quality, and Satisfaction for Standardized Patients with Depression,” Journal of General Internal Medicine 22, no. 12 (2007): 1641-1647; L. Hemel et al., The Kaiser Family Foundation and the Commonwealth Fund, Experiences and Attitudes of Primary Care Providers Under the First Year of ACA Coverage Expansion, June 18, 2015, available at <http://www.commonwealthfund.org/publications/issue-briefs/2015/jun/primary-care-providers-first-year-aca> (last visited February 22, 2018).CrossRefGoogle Scholar
See Dugdale, D.C., Epstein, R., and Pantilat, S.Z., “Time and the Patient-Physician Relationship,” Journal of General Internal Medicine 14, no. 1 (1999): S34-40; R.C. Rabin, “15-Minute Visits Take A Toll on The Doctor-Patient Pelationship,” Kaiser Health News, April 21, 2014, available at <https://khn.org/news/15-minute-doctor-visits/> (last visited at February 22, 2018).Google Scholar
Shaw, M.K., Davis, S.A., Fleischer, A.B., and Feldman, S.R., “The Duration of Office Visits in the United States, 1993 to 2010,” American Journal of Managed Care 20, no. 10 (2014): 820-826.Google Scholar
Beasley, J.W. et al., “How Many Problems do Family Physicians Manage at Each Encounter? A WReN study,” Annals of Family Medicine 2, no. 5 (2004): 405410.Google Scholar
American Academy of Family Physicians, Letter to Andrew M. Slavitt, Acting Administrator, available at <https://www.aafp.org/dam/AAFP/documents/advocacy/payment/medicare/feesched/LT-CMS-MPFS-122216.pdf> (last visited at February 22, 2018).+(last+visited+at+February+22,+2018).>Google Scholar
See, for example, Gungor, S., “Do You Need to See an Interventional Pain Specialist,” HSS The Playbook, available at <https://www.hss.edu/playbook/do-you-need-to-see-an-interventional-pain-specialist/> (last visited February 22, 2018).+(last+visited+February+22,+2018).>Google Scholar
See Meier, B. and Goodnough, A., “New Ways to Treat Pain Meet Resistance,” New York Times, June 22, 2016, available at <https://www.nytimes.com/2016/06/23/business/new-ways-to-treat-pain-without-opioids-meet-resistance.html?_r=0> (last visited February 22, 2018).+(last+visited+February+22,+2018).>Google Scholar
See Thomas, K. and Ornstein, C., “Amid Opioid Crisis, Insurers Restrict Pricey, Less Addictive Painkillers,” New York Times, September 17, 2017, available at <https://www.nytimes.com/2017/09/17/health/opioid-painkillers-insurance-companies.html> (last visited February 23, 2018).+(last+visited+February+23,+2018).>Google Scholar
National Association of Attorneys General, Letter to Marilyn Tavenner, President and CEO of America’s Health Insurance Plans, September 18, 2017, at <https://ag.ny.gov/sites/default/files/final_naag_opioid_letter_to_ahip.pdf> (last visited February 22, 2018).+(last+visited+February+22,+2018).>Google Scholar
See Meier, supra note 63; Lee, B.Y., “16 Insurance Companies Make Commitment To Address Opioid Crisis,” Forbes, November 9, 2017, <https://www.forbes.com/sites/brucelee/2017/11/09/16-insurance-companies-make-commitment-to-address-opioid-crisis/#617491aa79de> (last visited February 22, 2018).+(last+visited+February+22,+2018).>Google Scholar
Patient Protection and Affordable Care Act. Public Law No: 111-148: H.R. 3590. March 23, 2010.Google Scholar
See Elder, N. et al., “Provision of Recommended Chronic Pain Assessment and Management in Primary Care: Does Patient-Centered Medical Home (PCMH) Recognition Make a Difference?,” Journal of American Board of Family Medicine 29, no. 4 (2016): 474-481.Google Scholar
The Commonwealth Fund, Brief, Affordable Care Act’s Payment Delivery System Reforms: A Progress Report at Five Years, May 2015, at <http://www.commonwealthfund.org/publications/issue-briefs/2015/may/aca-payment-and-delivery-system-reforms-at-5-years> (last visited February 22, 2018). But see: J.M. McWilliams et al., “Early Performance of Accountable Care Organizations in Medicare,” NEJM 374, no. 24 (2016): 2357-2366.+(last+visited+February+22,+2018).+But+see:+J.M.+McWilliams+et+al.,+“Early+Performance+of+Accountable+Care+Organizations+in+Medicare,”+NEJM+374,+no.+24+(2016):+2357-2366.>Google Scholar
Brownstein, M.J., “A Brief History of Opiates, Opioid Peptides, and Opioid Receptors,” Proceedings of the National Academy of Sciences of the United States of America 90, no. 12 (1993): 5391-5393; Drug Enforcement Administration Museum and Visitor’s Center, Cannabis, Coca, & Poppy: Nature’s Addictive Plants, available at <https://www.deamuseum.org/ccp/opium/history.html> (last visited February 22, 2018).Google Scholar
See Brownstein, supra note 70.Google Scholar
Vowles, K.E. et al., “Rates of Opioid Misuse, Abuse, and Addiction in Chronic Pain: a Systematic Review and Data Synthesis,” Pain 156, no. 4 (2015): 569-576.Google Scholar
National Institute on Drug Abuse, The Science of Drug Abuse and Addiction: The Basics, Last Updated October 2016, available at <https://www.drugabuse.gov/publications/media-guide/science-drug-abuse-addiction-basics> (last visited February 22, 2018).+(last+visited+February+22,+2018).>Google Scholar
Armstrong, D., “Once-a-month Shot for Opioid Addiction Works as Well as Daily Medication, Study Finds,” STAT, October 28, 2017, at <https://www.statnews.com/2017/10/18/opioid-addiction-vivitrol-suboxone/> (last visited February 22, 2018).+(last+visited+February+22,+2018).>Google Scholar
Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, “History of Medication-Assisted Treatment for Opioid Addiction,” in Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs (Rockville, MD: 2005), available through <https://www.ncbi.nlm.nih.gov/books/NBK64157/> (last visited April 3, 2018).+(last+visited+April+3,+2018).>Google Scholar
“Methadone Diversion Control,” in Rettig, R.A. and Yarmolinsky, A. eds., Federal Regulation of Methadone Treatment (Washington: Academies Press, 1995), available at <https://www.ncbi.nlm.nih.gov/books/NBK232116//> (last visited May 31, 2018); see also: B. Mund and K. Stith, “Buprenorphine MAT as an Imperfect Fix,” Journal of Law, Medicine & Ethics 46, no. 2 (2018): 279-291.Google Scholar
But see Id.Google Scholar
Vestal, C., “How Severe is the Shortage of Substance Abuse Specialists?,” STATELINE, Pew Charitable Trusts, April 01, 2015, available at <http://www.pewtrusts.org/en/research-and-analysis/blogs/stateline/2015/4/01/how-severe-is-the-shortage-of-substance-abuse-specialists> (last visited February 22, 2018).Google Scholar
Andrilla, C.H., Coulthard, C., and Larson, E.H., “Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder,” Annals of Family Medicine 15, no. 4 (2017): 359-362, at 361; see also: E. Hutchinson et al., “Barriers to Primary Care Physicians Prescribing Buprenorphine,” Annals of Family Medicine 12, no. 2 (2014): 128-133.CrossRefGoogle Scholar
Id.; see also: Suzuki, J. et al., “Implementation of a Collaborative Care Management Program with Buprenorphine in Primary Care: A Comparison Between Opioid-Dependent Patients and Chronic Pain Patients using Opioids Non-medically,” Journal of Opioid Management 10, no. 3 (2014): 159-168.CrossRefGoogle Scholar
See American Society of Addiction Medicine, Nurse Practitioners and Physician Assistants Prescribing Buprenorphine, available at <https://asam.org/resources/practice-resources/nurse-practitioners-and-physician-assistants-prescribing-buprenorphine> (last visited April 3, 2018).+(last+visited+April+3,+2018).>Google Scholar
Quest, T.L. et al., “Buprenorphine Therapy for Opioid Addiction in Rural Washington: The Experience of the Early Adopters,” Journal of Opioid Management 8, no. 1 (2012): 29-38.CrossRefGoogle Scholar
Sharma, A. et al., “Update on Barriers to Pharmacotherapy for Opioid Use Disorders,” Current Psychiatry Reports 19, no. 35 (2017): 1-8.CrossRefGoogle Scholar
Substance Abuse and Mental Health Services Administration, Apply to Increase Patient Limits, Last Updated February 9, 2017, available at <https://www.samhsa.gov/medication-assisted-treatment/buprenorphine-waiver-management/increase-patient-limits> (last visited February 22, 2018).+(last+visited+February+22,+2018).>Google Scholar
See American Society of Addiction Medicine, supra note 81.Google Scholar
Klasa, K. et al., “Primary Care Models for Treating Opioid use Disorders: What Actually Works? A Systematic Review,” PLOS ONE 12, no. 10 (2017): 1-40. See also: Andrilla, supra note 79.Google Scholar
Hudgins, C., Rose, S., Fifield, P.Y., and Arnault, S., “Navigating the Legal and Ethical Foundations of Informed Consent and Confidentiality in Integrated Primary Care,” Families, Systems, & Health 31, no. 1 (2013): 9-19.CrossRefGoogle Scholar
Hedden, S.L. et al., Center for Behavioral Health Statistics and Quality, Substance and Mental Health Services Administration, Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health, September 2015, available at <https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf> (last visited February 22, 2018): at 33.+(last+visited+February+22,+2018):+at+33.>Google Scholar
See American Board of Preventative Medicine, Addiction Medicine Pathways, available at <https://www.theabpm.org/become-certified/subspecialties/addiction-medicine/addiction-medicine-pathways/> (last visited February 22, 2018).+(last+visited+February+22,+2018).>Google Scholar
See Klasa, supra note 86.Google Scholar
Lee, M. et al., “A Comprehensive Review of Opioid-Induced Hyperalgesia,” Pain Physician 14, no. 2 (2011): 145-161.Google Scholar
Cunningham, J.A. et al., “Barriers to Treatment – Why Alcohol and Drug-Abusers Delay or Never Seek Treatment,” Addictive Behaviors 18, no. 3 (1993): 347-353.CrossRefGoogle Scholar
Louma, J.B., “Stigma Predicts Residential Treatment Length for Substance use Disorder,” American Journal of Drug and Alcohol Abuse 40, no. 3 (2014): 206-212.CrossRefGoogle Scholar
Botticelli, M.P. and Koh, H.K., Viewpoint, “Changing the Language of Addiction,” JAMA 316, no. 13 (2016): 1361-1362; L.M. Broyles et al., “Confronting Inadvertent Stigma and Pejorative Language in Addiction Scholarship: a Recognition and Response,” editorial, Substance Abuse 35, no. 3 (2014): 217-221.Google Scholar
Schwartz, R.P., Commentary, “When Added to Opioid Agonist Treatment, Psychosocial Interventions do not Further Reduce the Use of Illicit Opioids: A Comment on Dugosh et al.,” Journal of Addiction Medicine 10, no. 4 (2016): 283-285.Google Scholar
Livingston, J.D. et al., “The Effectiveness of Interventions for Reducing Stigma Related to Substance use Disorders: a Systematic Review,” Addiction 107, no. 1 (2012): 39-50.Google Scholar
Tobin, D.G., “A Rational Approach to Opioid use Disorder in Primary Care” Cleveland Clinic Journal of Medicine 84, no. 5 (2017):385-387.Google Scholar
Katerndahl, D., Wood, R., and Jaen, C.R., “Complexity of Ambulatory Care across Disciplines,” Healthcare 3, no. 2 (2015): 89-96, at 93-94.CrossRefGoogle Scholar
Berenson, R.A. and Goodson, J.D. “Finding Value in Unexpected Places — Fixing the Medicare Physician Fee Schedule,” perspective, NEJM 374, no. 14 (2016): 1306-1309.CrossRefGoogle Scholar
See Thomas, supra note 64.Google Scholar
See Andrilla et al., supra note 79; see also: Johnson, S.R., “Proven Tool to Fight Opioid Abuse Underused by Providers,” Modern Healthcare, April 2, 2016, available at <http://www.modernhealthcare.com/article/20160402/MAGAZINE/304029964> (last visited February 23, 2018).+(last+visited+February+23,+2018).>Google Scholar
See Hedden et al., supra note 88.Google Scholar
See Hutchinson et al., supra note 79; Quest et al., supra note 82.Google Scholar
Haffajee, R.L., Jena, A.B., and Weiner, S.G., “Mandatory Use of Prescription Drug Monitoring Programs,” viewpoint, JAMA 313, no.9 (2015): 891-892.CrossRefGoogle Scholar
Department of Health and Human Services, Prescription Drug Monitoring Program Interoperability Standards: A Report to Congress, September 2013, available at <https://www.healthit.gov/sites/default/files/fdasia1141report_final.pdf> (last visited February 23, 2018).+(last+visited+February+23,+2018).>Google Scholar
See Rhode Island Department of Health, Rules and Regulations for Pain Management Opioid Use and the Registration of Distributors of Controlled Substances in Rhode Island, February 2017, available at <http://sos.ri.gov/documents/archives/regdocs/released/pdf/DOH/8473.pdf> (last visited February 23, 2018): at 6-7.+(last+visited+February+23,+2018):+at+6-7.>Google Scholar
Breuer, B., Pappagallo, M., Tai, J.Y., and Portenoy, R.K., “US Board Certified Pain Physician Practices: Uniformity and Census Data of their Locations,” Journal of Pain 8, no. 3 (2007): 244250.Google Scholar
42 C.F.R. § 2.13(d) (eff. March 21, 2017).Google Scholar
See Federal Register, Confidentiality of Substance Use Disorder Patient Records, January 9, 2018, available at <https://www.federalregister.gov/documents/2018/01/09/2018-00150/confidentiality-of-substance-use-disorder-patient-records> (last visited February 23, 2018).+(last+visited+February+23,+2018).>Google Scholar
Walley, A.Y. et al., “Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and Barriers,” Journal of General Internal Medicine 23, no. 9 (2008): 1393-1398.CrossRefGoogle Scholar
Substance Abuse and Mental Health Services Administration, Qualify for Nurse Practitioners (NPs) and Physician Assistants (Pas) Waiver, Last Updated January 18, 2018, available at <https://www.samhsa.gov/medication-assisted-treatment/qualify-nps-pas-waivers> (last visited February 23, 2018).+(last+visited+February+23,+2018).>Google Scholar
See Breuer et al., supra note 107.Google Scholar
See American Academy of Pain Medicine, For the Primary Care Provider; When to Refer to a Pain Specialist, December 1, 2016, available at <http://www.painmed.org/files/when-to-refer-a-pain-specialist.pdf> (last visited February 23, 2018).+(last+visited+February+23,+2018).>Google Scholar
See Gluck, A.R., Hall, A., and Curfman, G., “Civil Litigation and the Opioid Epidemic: The Role of Courts in a National Health Crisis,” Journal of Law, Medicine & Ethics 46, no. 2 (2018): 351-366Google Scholar
See, for example, American Academy of Family Physicians, Consultations, Referrals, and Transfers of Care, available at <https://www.aafp.org/about/policies/all/consultations-transfers.html> (last visited February 23, 2018).+(last+visited+February+23,+2018).>Google Scholar
Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, “Policies and Procedures,” in Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction in (Rockville, MD, Substance Abuse and Mental Health Services Administration: 2005), available at <https://www.ncbi.nlm.nih.gov/books/NBK64234/> (last visited February 23, 2018).+(last+visited+February+23,+2018).>Google Scholar
See State of Vermont, Hub and Spoke, available at <http://blueprintforhealth.vermont.gov/about-blueprint/hub-and-spoke> (last visited February 23, 2018).+(last+visited+February+23,+2018).>Google Scholar
Brooklyn, J.R. and Sigmon, S.C., “Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact,” Journal of Addiction Medicine 11, no. 4 (2017): 286-292.CrossRefGoogle Scholar
Doorenbos, A. et al.,“TelePain: Improving primary care pain management,” Journal of Pain 18, no. 4 (2017): S67-68.Google Scholar
See Providers Clinical Support System, available at <https://pcssnow.org/> (last visited February 23, 2018).+(last+visited+February+23,+2018).>Google Scholar